1. Home
  2. VFF vs KALV Comparison

VFF vs KALV Comparison

Compare VFF & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Village Farms International Inc.

VFF

Village Farms International Inc.

HOLD

Current Price

$4.11

Market Cap

462.1M

Sector

N/A

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$17.00

Market Cap

551.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VFF
KALV
Founded
1989
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
462.1M
551.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VFF
KALV
Price
$4.11
$17.00
Analyst Decision
Buy
Strong Buy
Analyst Count
1
8
Target Price
N/A
$26.43
AVG Volume (30 Days)
2.8M
1.6M
Earning Date
11-10-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.19
N/A
Revenue
$351,979,000.00
$1,426,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.62
$204.16
P/E Ratio
$21.47
N/A
Revenue Growth
56.61
N/A
52 Week Low
$0.45
$7.30
52 Week High
$4.32
$17.28

Technical Indicators

Market Signals
Indicator
VFF
KALV
Relative Strength Index (RSI) 62.68 70.46
Support Level $3.17 $15.88
Resistance Level $3.58 $17.10
Average True Range (ATR) 0.24 1.08
MACD -0.01 0.22
Stochastic Oscillator 80.01 96.52

Price Performance

Historical Comparison
VFF
KALV

About VFF Village Farms International Inc.

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Leli . The company makes majority of its revenue from the Produce segment.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: